Skip to main content
Premium Trial:

Request an Annual Quote

Power3 Medical Products Acquires ProteEx for $15M

NEW YORK, May 24 (GenomeWeb News) - Power3 Medical Products has acquired proteomics start-up ProteEx for $15 million, the company said last week.


Power3, a holding company , purchased ProteEx, based in The Woodlands, Texas, for 15 million shares of its common stock, worth approximately $15 million. Following the acquisition, Power3, which had $12,000 in revenues during the first quarter of 2004, mainly from selling a surgical safety device, will move its offices to ProteEx's site.


ProteEx, previously known as Advanced Bio/Chem, has been developing biomarkers for breast cancer in collaboration with the MD Anderson Cancer Center.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.